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Paragonimiasis is an infection caused by lung flukes of the genus *Paragonimus*. As many as 9 species of *Paragonimus* are responsible for human infections worldwide ([@R-2-1]). Human paragonimiasis is common in Asia, where diets often include raw, cured, pickled, or salted crustaceans ([@R-2-2]*,*[@R-2-3]). In contrast, consumption of uncooked crustaceans is uncommon in North America.

In North America, paragonimiasis is caused by *Paragonimus* *kellicotti* flukes ([@R-2-4]). *Paragonimus* spp. lung flukes have a complex life cycle, requiring snail and crustacean intermediate hosts. Definitive hosts excrete eggs in feces or sputum, which hatch in water to become ciliated miracidia. The miracidia invade soft tissue of snails where they reproduce asexually. Cercariae released from snails invade the secondary intermediate host, a crustacean. Secondary intermediate hosts for *P. kellicotti* flukes are crayfish in the genera *Cambarus* and *Orconectes*. Mammals acquire the infection when they ingest raw or undercooked crustaceans ([@R-2-5]). *P. kellicotti* fluke infections have been found in cats, dogs, bobcats ([@R-2-6]), raccoons ([@R-2-7]), foxes ([@R-2-8]*,*[@R-2-9]), skunks ([@R-2-9]), minks ([@R-2-9]*,*[@R-2-10]), and coyotes ([@R-2-9]). Human infections are uncommon; only 7 cases were reported during 1968--2008 ([@R-2-2]*,*[@R-2-11]*--*[@R-2-18])

In 2009, we reported a cluster of 3 patients who had probable or proven paragonimiasis caused by *P. kellicotti* flukes and who were seen at a single tertiary-care center over an 18-month period ([@R-2-19]). We report an additional 6 patients seen at Washington University Medical Center, St. Louis, Missouri, and at an affiliated Veterans Administration hospital over 14 months (September 2009--October 2010). The purpose of this report is to emphasize that *P. kellicotti* flukes are an emerging pathogen in Missouri, to highlight unusual clinical features observed in these patients, to educate the public in hopes of preventing new cases, and to increase awareness among the medical community to promote early diagnosis and treatment.

Patients, Materials, and Methods
================================

Patients with proven or probable *P. kellicotti* fluke infection seen at Washington University School of Medicine and an affiliated Veterans Administration Hospital during September 2009--October 2010 were identified at time of clinical encounter. Patient characteristics, case histories, and laboratory values were obtained from medical records by infectious disease physicians. Immunoblot tests were performed at the Centers for Disease Control and Prevention (Atlanta, GA, USA), commercial laboratories, or Washington University School of Medicine as described in the [Technical Appendix](#SD1){ref-type="local-data"}.

Results
=======

Clinical Features
-----------------

Patient characteristics for the combined series of 9 patients are summarized in [Table 1](#T-2-1){ref-type="table"} and [Table 2](#T-2-2){ref-type="table"}, and detailed case descriptions for the 6 new patients are provided in the [Technical Appendix](#SD1){ref-type="local-data"}. The patients included in this series were predominantly male (88.9%), and all but 1 were adults. Patients consumed raw crayfish while on float (recreational river) trips (7/9, 77.8%), camping (1/9, 11.1%), or as a demonstration of wilderness survival skills (1/9, 11.1%). Alcohol consumption at the time of crayfish consumption was common (7/9, 77.8%). Although there were differences in timing of seeking care and signs and symptoms, patients in this series frequently had cough (100%), fever (88.9%), and eosinophilia (100%).

###### Characteristics of 9 patients infected with *Paragonimus kellicotti* flukes, Missouri, USA, September 2009--October 2010\*

  Patient no.   Age, y/sex   Location                        Incubation period, wk   Signs and symptoms                                                                    Time to diagnosis, wk   Method of diagnosis                                       Reference
  ------------- ------------ ------------------------------- ----------------------- ------------------------------------------------------------------------------------- ----------------------- --------------------------------------------------------- -------------
  1             31/M         Jacks Fork and Current Rivers   2                       Fever, pharyngitis, cough, dyspnea, eosinophilia                                      3                       Clinical history                                          ([@R-2-19])
  2             26/F         Meramec River                   2                       Fatigue, cough, fever, eosinophilia                                                   12                      Serologic analysis                                        ([@R-2-19])
  3             32/M         Current River                   3                       Fever, malaise, cough, headache, eosinophilia                                         12                      Serologic analysis                                        ([@R-2-19])
  4             28/M         Huzzah River                    8                       Fever, myalgia, malaise, cough, weight loss, eosinophilia                             12                      Clinical history                                          NA
  5             10/M         Current River                   16                      Fever, myalgia, malaise, cough, chest pain, weight loss, eosinophilia                 3                       Clinical history                                          NA
  6             20/M         Jacks Fork River                12                      Fever, night sweats, malaise, cough, dyspnea, chest pain, weight loss, eosinophilia   36                      Serologic analysis                                        NA
  7             22/M         Jacks Fork River                6                       Fever, night sweats, cough, dyspnea, chest pain, weight loss, eosinophilia            40                      Serologic analysis, sputum ova and parasite examination   NA
  8             30/M         Jacks Fork River                2                       Fever, night sweats, malaise, cough, dyspnea, chest pain, weight loss, eosinophilia   16                      Serologic analysis                                        NA
  9             43/M         Missouri River                  12                      Cough, dyspnea, chest pain, weight loss, eosinophilia                                 83                      Serologic analysis                                        NA

\*Patients 4--9 were not previously reported. NA, not applicable.

###### Clinical and laboratory findings for 9 patients infected with *Paragonimus kellicotti* flukes, Missouri, USA, September 2009--October 2010\*

  Characteristic                                                Value
  ------------------------------------------------------------- --------------------
  Age, y, median (range)                                        28 (10--43)
  Male sex                                                      8 (88.9)
  Alcohol consumption                                           7 (77.8)
  Incubation period, wk, median (range)                         4 (2--12)
  Duration of symptoms before examination, wk, median (range)   2 (2--8)
  Signs and symptoms                                            
  Fever                                                         8 (88.9)
  Cough                                                         9 (100.0)
  Chest pain                                                    6 (66.7)
  Dyspnea                                                       4 (44.4)
  Night sweats                                                  5 (55.6)
  Malaise                                                       5 (55.6)
  Abdominal pain                                                2 (22.2)
  Weight loss                                                   7 (77.8)
  Laboratory findings                                           
  Eosinophils/mm^3^ at first examination, mean (range)          1,626 (800--3,600)
  \% Eosinophils at first examination, mean (range)             15 (6--30)
  Positive paragonimus immunoblot result†                       5 (71.4)
  Positive sputum ova and parasite test result†                 1 (14.2)
  Radiographic findings                                         
  Pleural effusion                                              9 (100.0)
  Nodule                                                        4 (44.4)
  Pericardial effusion                                          4 (44.4)

\*Values are no. (%) unless otherwise indicated. †n = 7.

Paragonimiasis can be difficult to diagnose in its early stages because of the nonspecific nature of initial symptoms. In some regions, paragonimiasis may be mistakenly diagnosed as tuberculosis. In this series of patients, initial diagnoses included pneumonia, bronchitis, influenza, gastroenteritis, acute cholecystitis, and pulmonary embolism. The median time between crayfish ingestion and the onset of clinical signs and symptoms was 4 weeks (range 2--12 weeks). The median interval between the onset of symptoms and the initial visit to health care facilities was 2 weeks (range 2--8 weeks). However, the median time from symptom onset to the correct diagnosis was 12 weeks (range 3--83 weeks). Before diagnosis of paragonimiasis, patients received multiple unnecessary medications and treatments, and these were sometimes associated with serious illness. All patients were treated with antimicrobial drugs.

*Clostridium difficile* infection developed in 1 patient after multiple courses of antimicrobial drug therapy. Six (67%) patients were treated with ≥l course of corticosteroids. One patient also underwent multiple thoracentesis procedures, and 1 of these procedures resulted in pneumothorax that required chest tube replacement. This patient also underwent decortication because of recurrent pleural effusions. One patient underwent laparoscopic cholecystectomy after having right upper quadrant pain. This finding may have been related to parasite migration across the diaphragm because the gallbladder did not show any pathologic changes.

Laboratory Test Results
-----------------------

Patients with paragonimiasis often have abnormal laboratory test results that are useful for making a diagnosis. Eosinophilia has been reported in 62%--66% of patients with infection caused by *P. westermani* flukes ([@R-2-20]*,*[@R-2-21]) and in 75% of patients with paragonimiasis in North America ([@R-2-19]). All patients in this series had eosinophilia at initial examination (absolute eosinophil count range 600 cells/mm^3^--2,300 cells/mm^3^, % range 5.6%--21%). Pleural fluid analysis showed eosinophilia in 3 patients. Chest radiographic findings were abnormal for all patients with paragonimiasis in North America ([@R-2-19]). Pleural effusions were present in 37% of paragonimiasis patients in Asia and in 60% of previously described patients in North America ([@R-2-19]*,*[@R-2-22]). All patients in this series had pleural effusions. Other chest radiographic findings included nodules, opacities, and infiltrates. Chest computed tomography scans showed pleural thickening, pericardial thickening, pericardial effusions, and worm nodules ([@R-2-23]).

Four of 6 patients in the current series had pericardial effusions documented by either computed tomography or echocardiography. Although most pericardial effusions were small and did not cause hemodynamic compromise, 1 patient had cardiac tamponade that required emergency pericardiocentesis and drain placement. Analysis of pericardial fluid showed marked eosinophilia. Eosinophilic pericardial effusions were documented in 3 children with paragonimiasis caused by *P. mexicanus* flukes in Costa Rica ([@R-2-24]*,*[@R-2-25]). Pericardial effusion has also been reported for 1 patient with paragonimiasis in Asia ([@R-2-26]). Pericardial effusions have not been reported for patients with *P. kellicotti* flukes infection, although various *Paragonimus* spp. flukes have been reported to invade soft tissue ([@R-2-19]*,*[@R-2-20]*,*[@R-2-27]*,*[@R-2-28]) and the central nervous system ([@R-2-19]*,*[@R-2-29]).

Serologic analysis can be useful for confirming a diagnosis of paragonimiasis. However, available serologic tests have limitations. An immunoblot for *P. westermani* flukes performed at the Centers for Disease Control and Prevention (Atlanta, GA, USA) has been reported to be highly sensitive (96%) and specific (99%) ([@R-2-30]). However, this assay has not been validated for *P. kellicotti* flukes. In our series, 2 patients had negative immunoblot results at the Centers for Disease Control and Prevention for samples that had been positive by Western blot with *P. kellicotti* fluke antigen at Washington University (G.J. Weil, et al., unpub. data). These patients had symptoms and abnormal laboratory test results suggestive of paragonimiasis after ingestion of raw crayfish, and their symptoms resolved after therapy with praziquantel. Diagnosis by identification of ova in sputum specimens is specific, but has low sensitivity (30%--40%) ([@R-2-1]). Ova were present in sputum from only 1 patient in our series ([@R-2-5]). Examination of stool for ova has low sensitivity (11%--15%) ([@R-2-31]*,*[@R-2-32]).

Response to Therapy
-------------------

Praziquantel (75 mg/kg in 3 divided doses for 2 days) is the treatment of choice for paragonimiasis in the United States ([@R-2-33]). Cure rates of 71%--75%, 86%--100%, and 100% have been reported with 1-, 2-, and 3-day courses, respectively ([@R-2-1]*,*[@R-2-34]). All patients in this series were treated with praziquantel for 2--3 days, and 7 (77.8%) experienced rapid clinical improvement or cure after treatment. One patient had some residual dyspnea and chest tightness 4 weeks after treatment. These findings may have been related to the protracted time between onset of his symptoms and initiation of appropriate therapy. He was asymptomatic at the 6-month follow-up visit. One atypical patient with chronic paragonimiasis who also had preexisting chronic obstructive pulmonary disease did not notice much improvement in his chronic dyspnea after praziquantel treatment, but defervescence and a weight gain of 30 pounds represented a clear clinical response to therapy.

Public Health Interventions
---------------------------

Control of this organism in the wild is not feasible because of the wide geographic distribution of crayfish and mammalian intermediate hosts that eat crayfish and serve as definitive hosts for the parasite. *P. kellicotti* flukes are highly prevalent among crayfish in rivers that are used for recreation in Missouri ([@R-2-5]). Effective prevention strategies should focus on physician education to improve awareness of this disease and education targeted at the general population. We worked with public health officials to help improve awareness of this disease in physicians and in the general public. For example, we assisted the Missouri Department of Health and Senior Services in creating a health advisory ([www.health.mo.gov/emergencies/ert/alertsadvisories/pdf/HAd4-30-10.pdf](http://www.health.mo.gov/emergencies/ert/alertsadvisories/pdf/HAd4-30-10.pdf)) for physicians in Missouri with the goal of educating physicians on the risk factors, clinical signs and symptoms, and treatment for this infection. In September 2009, we collaborated with the Missouri Department of Health and Senior Services and the Missouri Department of Natural Resources to create a warning poster ([www.health.mo.gov/living/environment/fishadvisory/pdf/crayfish.pdf](http://www.health.mo.gov/living/environment/fishadvisory/pdf/crayfish.pdf)) that was posted at canoe rental facilities and campgrounds along rivers in Missouri. This poster warned the general public about the risk for consuming raw crayfish.

In addition, during the spring of 2010, four of the authors (M.A.L., L.M.D., T.C.B., G.J.W.) provided information to local and national print, radio, and television media to increase awareness of this infection. Three cases were identified after this media campaign. One patient sought care at our medical facility after his mother, a nurse, saw an article about paragonimiasis in her local newspaper. One patient was referred to our clinic by a friend who had seen a report on paragonimiasis on a local television station. Another patient had atypical features, but increased physician awareness helped to establish the diagnosis in this patient.

Discussion
==========

Although only a small number of cases of human paragonimiasis have been described in the medical literature since 1984, we have seen 9 patients with this disease in St. Louis since 2006. Five other patients with this disease in Missouri have been reported to the Missouri Department of Health and Senior Services since 2009 (P. Lo, pers. comm.). *P. kellicotti* flukes are believed to be widely distributed throughout the North America. In addition, outdoor activities such as camping and float trips when combined with alcohol consumption are not uniquely confined to Missouri. It is likely that there are case-patients in other regions who have not been given a diagnosis or treated. Although most patients reported to date have been adults, this series shows that children are also at risk for infection if they ingest uncooked crayfish.

As this patient series demonstrates, delayed diagnosis can lead to unnecessary medical treatments and procedures that can cause serious illness. Clinicians should consider the diagnosis of paragonimiasis in all patients with cough, fever, and pleural effusion with peripheral eosinophilia. We are developing a new antibody assay that may help clinicians identify and treat patients with this infection. Additional efforts to raise awareness of this parasite among physicians will potentially help appropriately identify and treat currently infected persons. These efforts should also target the general public to warn them of the dangers of consuming raw crayfish.

###### Technical Appendix

Detailed case descriptions for 6 new patients infected with *Paragonimus kellicotti* flukes, Missouri, USA, September 2009--2013;October 2010.
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**1. You are seeing a 24-year-old man with a 4-week history of cough, fever, and malaise. He was seen in an urgent care center 10 days ago and prescribed a course of macrolide antibiotics, which did not improve his symptoms. On questioning, the symptoms began after a camping trip in which the patient and his friends experimented with eating raw meat and seafood.**

**You are concerned regarding the possibility of paragonimiasis in this patient. What should you consider regarding the epidemiology and microbiology of paragonimiasis?**

A. Most cases are reported in North America

B. *P. kellicotti* requires snail and crustacean intermediate hosts

C. Humans usually are infected after eating escargot

D. *P. kellicotti* infects only humans

**2. What should you consider regarding the clinical presentation of paragonimiasis in the current case series as you evaluate this patient?**

A. All patients were female

B. Cough and fever were the most common clinical symptoms

C. Vomiting and malaise were the most common clinical symptoms

D. The onset of symptoms occurred within 48 hours of ingesting food contaminated with *P. kellicotti*

**3. What should you consider regarding the management of paragonimiasis in the current case series as you evaluate this patient?**

A. The median time from symptom onset to the correct diagnosis was 12 weeks

B. Only half of patients had received antibiotic therapy

C. No patients had received corticosteroids

D. Most patients failed to respond even to appropriate antiparasitic therapy

**4. Which of the following tests is most likely to be abnormal if this patient has paragonimiasis?**

A. Serum neutrophil counts

B. Serum eosinophil counts

C. Serum sodium levels

D. Electrocardiogram
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